SCHEMBL6172844

SCHEMBL6172844

CC(c1ccncc1NC(N)=O)C1(C(C)c2ccncc2NC(N)=O)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TRPV1 Q8NER1 1/20 0.36
FLT1 P17948 3/20 0.35
KDR P35968 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
POLB P06746 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
P2RY2 P41231 1/20 0.33
P2RY1 P47900 1/20 0.33
P2RY14 Q15391 1/20 0.33
LMNA P02545 1/20 0.33
NAMPT P43490 2/20 0.33
CXCR3 P49682 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173454 0.92 CYP2C9 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174515 0.90 ALDH1A1 (0.45) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175907 0.89 ALDH1A1 (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6175486 0.88 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174412 0.88 MAPT (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173573 0.88 CACNA1H (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6278206 0.88 TRPV1 (0.49) ALDH1A1TRPV1NAMPTCXCR3KDM5A
SCHEMBL6172977 0.88 CYP3A4 (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173283 0.87 CYP3A4 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174469 0.87 TDP1 (0.42) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed